AXIS 2: AX200 for the Treatment of Ischemic Stroke "AXIS-2"


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to assess the efficacy of AX200 (filgrastim) in the treatment of acute ischemic stroke and to assess the safety and tolerability of AX200.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 December 2011.

1 May 2009 24 Jun 2009 1 Nov 2011 1 Nov 2011 1 Aug 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available